Top Markets
Coin of the day
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Clasificación en acciones #33995
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Precio por acción
$0.1502
Última sincronización: 2024-11-04
Capitalización bursátil
$6.43M
Cambio (1 día)
-5.45%
Cambio (1 año)
0.00%
País
US
Comercio Renalytix Plc (RNLX)

Categoría

EPS de Renalytix Plc (RNLX)
EPS a fecha de September 2024 TTM: $-0.52
Según los últimos informes financieros y el precio de las acciones de Renalytix Plc, el EPS actual de la empresa (TTM) es $-0.52. Al final del año 2023, la empresa tenía un EPS de $-1.10 una disminución en comparación con al EPS de 2022, que fue de $-1.24.
Historial de EPS de Renalytix Plc desde 2018 hasta 2026
EPS al final de cada año
Año EPS Cambiar
2026 (TTM) $-0.52 -16.13%
2024 $-0.62 -43.64%
2023 $-1.10 -11.29%
2022 $-1.24 26.53%
2021 $-0.98 188.24%
2020 $-0.34 -82.83%
2019 $-1.98 3,200.00%
2018 $-0.06 0.00%
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$3.48 -769.23%
US
$1.50 -388.62%
AU
$1.43 -375.00%
US
$-1.43 175.00%
US
- -
US